Prediction of functional recovery after revascularization in coronary artery disease using 18F-FDG and 123I-BMIPP SPECT

Chest

Volumn 117, Issue 1, 2000, Pages 65-72

  Sato, Hideki ^a   Iwasaki, Tsutomu ^a   Toyama, Takuji ^a   Kaneko, Yoshiaki ^a   Inoue, Tomio ^a   Endo, Keigo ^a   Nagai, Ryozo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

123I methyl iodophenyl pentadecanoic acid; 18F fluorodeoxyglucose; Coronary artery disease; Functional recovery; Single photon emission CT

Indexed keywords

DECANOIC ACID DERIVATIVE; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; FATTY ACID METABOLISM; FEMALE; FUNCTION TEST; GLUCOSE METABOLISM; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HUMAN; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033957605     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.1.65     Document Type: Article

References (31)

1. 1 Burt RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995; 36:176-179
2. 2 Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995; 36:988-995
3. 3 Bax JJ, Visser FC, Blanksma PK, et al. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med 1996; 37:1631-1636
4. 4 Chen EQ, MacIntyre WJ, Go RT, et al. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET. J Nucl Med 1997; 38:582-586
5. 5 Opie LH. Metabolism of the heart in health and disease: part I. Am Heart J 1988; 76:685-698
6. 6 Van der Vusse GJ, Glatz JFC, Stam HCG, et al. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992; 72:881-940
7. 7 Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995; 22:361-381
8. 8 Knapp FF Jr, Kropp J, Franken PR. Pharmacokinetics of radioiodinated fatty acid myocardial imaging agents in animal and human studies: invited review. Q J Nucl Med 1996; 40:252-269
9. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1996; 21:283-291
10. 10 Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995; 36:1022-1030
11. 201Tl-SPECT images. Eur J Nucl Med 1996; 23:917-923
12. 12 Nohara R, Okuda K, Ogino M, et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996; 37:1403-1407
13. 13 Tamaki N, Tadamura E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995; 36:1974-1980
14. 14 Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Medl992; 33: 659-667
15. 15 Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8:47-54
16. 16 Lucignani G, Paolini G, Landoni G, et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2 methoxyisobutylisonitrile single photon emission computed tomography and fluorine-18-fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992; 19:874-881
17. 17 Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of Tc-99m-sestamibi with thallium reinjection and F-18-fluorodeoxyglucose. Circulation 1994; 89:578-587
18. 18 Altehoefer C, vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35:569-574
19. 19 Sawada SG, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m-sestamibi defects. J Am Coll Cardiol 1994; 23:92-98
20. 20 Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization: comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28:558-564
21. 21 Bax JJ, Cornel JH, Visser FC, et al. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization. J Nucl Cardiol 1997; 4:302-308
22. 22 Nuyts J, Dupont P, Van-den-Maegdenbergh V, et al. A study of the liver-heart artifact in emission tomography. J Nucl Med 1995; 36:133-139
23. 23 Matsunari I, Boning G, Ziegler SI, et al. Attenuation-corrected rest thallium/stress technetium 99m sestamibi myocardial SPECT in normals. J Nucl Med 1998; 5:48-55
24. 99mTc sestamibi SPECT. J Nucl Cardiol 1998; 5:4-13
25. 18F]Fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation 1998; 97:843-850
26. 26 Welty FK, Mittleman MA, Lewis SM, et al. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol 1995; 76:431-435
27. 27 Haim M, Hod H, Reisin L, et al. Comparison of short-and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction: Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Am J Cardiol 1997; 79:717-721
28. 28 Gropler RJ, Siegel BA, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after infarction. J Am Coll Cardiol 1992; 19:989-997
29. 29 Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993; 22:1587-1597
30. 30 Nelly JR, Rovetto M, Oran JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15:289-301
31. 31 Cornel JH, Bas JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998; 5:1002-1010